Performance of CGEM Cullinan Oncology LLC | 152.7% in 12m
Compare CGEM with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Cullinan Oncology LLC with its related Sector/Index XBI
Performance Duell CGEM vs XBI
| TimeFrame | CGEM | XBI |
|---|---|---|
| 1 Day | -2.69% | -1.52% |
| 1 Week | -11.3% | 1.45% |
| 1 Month | 48.0% | 10.08% |
| 3 Months | 33.2% | -1.30% |
| 6 Months | 164.5% | 24.09% |
| 12 Months | 152.7% | 6.83% |
| YTD | 118.8% | 1.05% |
| Rel. Perf. 1m | 2.30 | |
| Rel. Perf. 3m | 8.17 | |
| Rel. Perf. 6m | 7.13 | |
| Rel. Perf. 12m | 9.13 |
Is Cullinan Oncology LLC a good stock to buy?
No, based on ValueRay Fundamental Analyses, Cullinan Oncology LLC (NASDAQ:CGEM) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -73.39 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGEM as of May 2024 is 28.15. This means that CGEM is currently undervalued and has a potential upside of +21.49% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGEM as of May 2024 is 28.15. This means that CGEM is currently undervalued and has a potential upside of +21.49% (Margin of Safety).
Is CGEM a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: CGEM is performing better - Values below 0%: CGEM is underperforming
Compare CGEM with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.97% | 41.03% | 147.11% | 124.36% |
| US NASDAQ 100 | QQQ | -13.29% | 39.01% | 148.44% | 117.52% |
| US Dow Jones Industrial 30 | DIA | -12.72% | 42.50% | 149.72% | 130.76% |
| German DAX 40 | DBXD | -11.09% | 42.81% | 147.34% | 138.29% |
| UK FTSE 100 | ISFU | -12.87% | 38.41% | 148.26% | 138.02% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.48% | 43.23% | 162.38% | 159.95% |
| Hongkong Hang Seng | HSI | -13.48% | 25.10% | 160.81% | 158.08% |
| Japan Nikkei 225 | EXX7 | -12.39% | 47.08% | 152.72% | 141.94% |
| India NIFTY 50 | INDA | -13.75% | 44.76% | 146.92% | 122.85% |
| Brasil Bovespa | EWZ | -11.24% | 44.67% | 168.26% | 139.96% |
CGEM Cullinan Oncology LLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.52% | 44.01% | 147.32% | 116.89% |
| Consumer Discretionary | XLY | -11.80% | 42.69% | 157.71% | 133.84% |
| Consumer Staples | XLP | -12.38% | 42.90% | 150.18% | 146.64% |
| Energy | XLE | -12.80% | 47.97% | 150.54% | 129.31% |
| Financial | XLF | -13.32% | 42.73% | 142.57% | 120.01% |
| Health Care | XLV | -13.32% | 42.66% | 150.19% | 139.42% |
| Industrial | XLI | -11.47% | 43.93% | 145.17% | 124.96% |
| Materials | XLB | -11.73% | 44.37% | 148.68% | 133.07% |
| Real Estate | XLRE | -13.57% | 39.93% | 155.70% | 141.81% |
| Technology | XLK | -13.90% | 37.94% | 149.84% | 117.07% |
| Utilities | XLU | -12.83% | 37.40% | 145.94% | 139.48% |
| Aerospace & Defense | XAR | -12.40% | 39.60% | 150.25% | 128.24% |
| Biotech | XBI | -12.78% | 37.88% | 140.41% | 145.84% |
| Homebuilder | XHB | -11.91% | 40.96% | 134.24% | 101.82% |
| Retail | XRT | -10.85% | 41.27% | 144.40% | 123.17% |
Does Cullinan Oncology LLC outperform its market, is CGEM a Sector Leader?
Yes, over the last 12 months Cullinan Oncology LLC (CGEM) made 152.67%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months CGEM made 33.16%, while XBI made -1.30%.
Yes, over the last 12 months Cullinan Oncology LLC (CGEM) made 152.67%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months CGEM made 33.16%, while XBI made -1.30%.
| Period | CGEM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 47.96% | 10.08% | 6.93% |
| 3 Months | 33.16% | -1.30% | 6.91% |
| 12 Months | 152.67% | 6.83% | 28.31% |